23andMe's new COVID-19 resource. Consumer genomics company 23andMe has released a new interactive tool that allows users to see how various health factors could impact the risk of COVID-19 hospitalization. The COVID-19 Severity Calculator pulls data from the company's COVID-19 study, which included 10,000 participants diagnosed with the disease and 750 who were hospitalized.
23andMe warned that...
Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services (CMS), and available to Medicare beneficiaries with diabetes who meet eligibility criteria.
Indicated for diabetes management in patients aged four years or older, the updated version of Abbott's system can...
LifeScan, a Johnson and Johnson company, just announced that its companion app, Reveal, for people with diabetes who use the OneTouch Verio Sync Meter, now enables data sharing with third party apps through Apple's HealthKit. The new functionality means Verio and Reveal users can now easily share their glucose numbers with any other health app that connects through Apple's HealthKit exchange....
"Everyone is going to look for solutions that not only improve care but also save healthcare dollars," MedApps CEO Kent Dicks told MobiHealthNews in a recent interview. "No one can dispute that."
MedApps navigated the early years of wireless health, first as a mobile phone-based solution, which the FDA approved in 2007, before switching to a connected, dedicated device, called HealthPAL. It's a...
